Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.385 USD | +2.59% | -6.71% | +18.80% |
May. 13 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
May. 09 | Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.80% | 101M | |
+10.46% | 118B | |
+10.28% | 106B | |
-10.82% | 23.4B | |
-2.01% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-14.76% | 15.97B | |
+6.44% | 14.03B | |
+14.36% | 11.67B |
- Stock Market
- Equities
- CLSD Stock
- News Clearside Biomedical, Inc.
- Wedbush Trims Clearside Biomedical's PT to $4 From $5 After Increased Share Count, Model Adjustments; Maintains Outperform Rating